LAMIVUDINE-ZIDOVUDINE TABLET

Lamivudine and Zidovudine
$0.6228per EA

Strength

150; 300 mg/1; mg/1

NDC

33342000309

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LAMIVUDINE; ZIDOVUDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA090679

On Market Since

8/30/2018

Price History

1W

0.0%

1M

+0.9%

3M

+11.8%

6M

-12.9%

1Y

+11.3%

3Y

-22.1%

5Y

-36.2%

All

-34.0%